Medico Intercontinental
MEDICOINTERCONTINENTALLTD NSE
Medico Intercontinental
Commercial ServicesNSE: MEDICOINTERCONTINENTALLTD BSE: 539938 Trading & Distributors
Key Fundamentals
MicrocapTrading & DistributorsCommercial ServicesMarket Cap
₹25.85 Cr
Volatility
Moderate
P/E Ratio
-2
EBITDA
₹2.97 Cr
Return on Equity
10.4%
Debt to Equity
1.43
Book Value
₹46.89
EPS
₹4.01
52W High
₹43
52W Low
₹20.61
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Stock is trading at 0.54 times its book value
- Promoter holding has increased by 1.36% over last quarter.
- Company's working capital requirements have reduced from 122 days to 76.2 days
Weaknesses
4- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.81% over past five years.
- Company has a low return on equity of 4.23% over last 3 years.
- Earnings include an other income of Rs.1.13 Cr.
Growth Rate
Revenue Growth
-12.78% lower than
3Y
Net Income Growth
-320% higher than
3Y
Cash Flow Change
-227% lower than
3Y
ROE
18.59% higher than
3Y
ROCE
0.32% higher than
3Y
EBITDA Margin (Avg.)
-61.8% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24.28 | 17.12 | 14.25 | 15.7 | 19.28 | 36.45 | 18.43 | 21.16 | 21.35 | 20.4 | 19.85 | 22.49 | 20.71 |
| Expenses | 22.8 | 15.81 | 12.76 | 14.15 | 17.64 | 33.74 | 16.52 | 19.22 | 20.67 | 21.28 | 18.26 | 20.88 | 21.4 |
| Operating Profit | 1.48 | 1.31 | 1.49 | 1.55 | 1.64 | 2.71 | 1.91 | 1.94 | 0.68 | -0.88 | 1.59 | 1.61 | -0.69 |
| OPM % | 6.1% | 7.65% | 10.46% | 9.87% | 8.51% | 7.43% | 10.36% | 9.17% | 3.19% | -4.31% | 8.01% | 7.16% | -3.33% |
| Other Income | 0.08 | 0.08 | 0.09 | 0.14 | 0.11 | 0.1 | 0.13 | 0.11 | 0.29 | 0.55 | 0.34 | 0.11 | 0.13 |
| Interest | 0.11 | 0.09 | 0.13 | 0.16 | 0.18 | 0.28 | 0.24 | 0.3 | 2.36 | 2.06 | 1.9 | 1.85 | 1.91 |
| Depreciation | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.2 | 0.23 | 0.28 | 0.62 | 1.95 | 1.43 | 1.43 | 1.21 |
| PBT | 1.38 | 1.23 | 1.38 | 1.45 | 1.49 | 2.33 | 1.57 | 1.47 | -2.01 | -4.34 | -1.4 | -1.56 | -3.68 |
| Tax % | 26.09% | 29.27% | 26.09% | 28.28% | 27.52% | 29.61% | 27.39% | 22.45% | 23.88% | 4.61% | 20% | 51.28% | 10.33% |
| Net Profit | 1.02 | 0.87 | 1.02 | 1.04 | 1.08 | 1.63 | 1.17 | 1.17 | -2.49 | -4.51 | -1.66 | -2.33 | -4.05 |
| EPS in Rs | 1.02 | 0.87 | 1.02 | 1.04 | 1.08 | 1.63 | 1.17 | 1.17 | -0.68 | -1.65 | -0.22 | -0.65 | -1.45 |
Profit & Loss
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 10 | 82 | 70 | 74 | 76 | 71 | 96 | 84 | 83 |
| Expenses | 0 | 9 | 78 | 65 | 69 | 71 | 66 | 88 | 81 | 82 |
| Operating Profit | 0 | 1 | 4 | 5 | 5 | 5 | 6 | 8 | 3 | 2 |
| OPM % | — | 7% | 5% | 7% | 7% | 7% | 8% | 9% | 3.5% | 1.9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 8 | 8 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 6 |
| PBT | 0 | 1 | 3 | 4 | 4 | 5 | 5 | 7 | -9 | -11 |
| Tax % | 40% | 27% | 26% | 27% | 27% | 27% | 27% | 28% | 19% | — |
| Net Profit | 0 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | -11 | -13 |
| EPS in Rs | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.95 | 5.06 | -3.2 | -3.97 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 3% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 1 | 3 | 6 | 9 | 31 | 35 | 39 | 37 |
| Borrowings | 0 | 0 | 14 | 9 | 9 | 5 | 5 | 17 | 67 |
| Other Liabilities | 1 | 5 | 16 | 12 | 11 | 13 | 6 | 10 | 3 |
| Total Liabilities | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 76 | 117 |
| Fixed Assets | 0 | 0 | 2 | 2 | 2 | 3 | 4 | 9 | 51 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 4 | 9 | 34 | 28 | 30 | 56 | 53 | 67 | 64 |
| Total Assets | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 76 | 117 |
Cash Flow
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 1 | -14 | 6 | 4 | -10 | 6 | -7 | 17 |
| Investing | 0 | 0 | 0 | -1 | -1 | -5 | -9 | -2 | 2 |
| Financing | 0 | 0 | 13 | -5 | -1 | 20 | 0 | 9 | -16 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 1 | 5 | -3 | -1 | 4 |
| Free Cash Flow | 0 | 1 | -14 | 5 | 4 | -11 | 4 | -9 | 12 |
| CFO/OP | -6 | 171 | -200 | 138 | 100 | -167 | 118 | -63 | 635 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | 237 | 101 | 94 | 84 | 157 | 119 | 125 | 119 |
| Inventory Days | 0 | 26 | 46 | 58 | 47 | 52 | 69 | 45 | 87 |
| Days Payable | — | 201 | 74 | 67 | 50 | 67 | 30 | 37 | 82 |
| Cash Conversion Cycle | — | 62 | 74 | 85 | 81 | 143 | 158 | 134 | 124 |
| Working Capital Days | — | 78 | 74 | 68 | 66 | 132 | 134 | 156 | 76 |
| ROCE % | — | 28% | 36% | 25% | 25% | 17% | 12% | 14% | -1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medico Intercontinental insights
58 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Compliances-Reg.24(A)-Annual Secretarial Compliance
16 Apr - FY2025-26 secretarial compliance report filed; no non-compliances, and BSE website observation was rectified. 16 Apr - FY2025-26 secretarial compliance report filed; no non-compliances, and BSE website observation was rectified.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
8 Apr - Company states it is not classified as a large corporate under SEBI debt fundraising framework. 8 Apr - Company states it is not classified as a large corporate under SEBI debt fundraising framework.
5
Announcement under Regulation 30 (LODR)-Credit Rating
2m - Of Credit Rating under Regulation 30 of SEBI (LODR) Regulation, 2015. 2m - Of Credit Rating under Regulation 30 of SEBI (LODR) Regulation, 2015.
Frequently Asked Questions about Medico Intercontinental
What does Medico Intercontinental Ltd do?
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
Where is Medico Intercontinental Ltd (539938) listed?
Medico Intercontinental Ltd trades as MEDICOINTERCONTINENTALLTD on the NSE and under code 539938 on the BSE.
Which sector does Medico Intercontinental Ltd belong to?
Medico Intercontinental Ltd is classified under the Commercial Services sector, in the Trading & Distributors industry.
What is the market capitalisation of Medico Intercontinental Ltd?
Medico Intercontinental Ltd has a market capitalisation of ₹25.85 Cr, which places it in the Small Cap band.
What is the PE ratio of Medico Intercontinental Ltd?
Medico Intercontinental Ltd trades at a PE ratio of -2.00, on earnings per share of ₹4.01, against a book value of ₹46.89 per share.
What is the 52-week high and low of Medico Intercontinental Ltd?
Over the last 52 weeks Medico Intercontinental Ltd has traded between ₹20.61 and ₹43.
Does Medico Intercontinental Ltd pay dividends?
Medico Intercontinental Ltd has a dividend yield of 0.40%.
What is the Return on Equity (ROE) of Medico Intercontinental Ltd?
Medico Intercontinental Ltd reported a return on equity of 10.40%. Its debt-to-equity ratio is 1.43.
Company Information
Incorporated in 1914, Medico Intercontinental Ltd is engaged in trading of Pharmaceutical products[1]
Website medicointercontinental.com
CEO Mr. Samir Dilipkumar Shah
Employees 38
Listed 2019-06-21
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539938.md for Medico Intercontinental Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.